CORRADINI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 8.224
EU - Europa 4.511
AS - Asia 3.740
SA - Sud America 598
AF - Africa 58
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.146
Nazione #
US - Stati Uniti d'America 8.126
IT - Italia 1.367
CN - Cina 1.327
GB - Regno Unito 1.260
SG - Singapore 1.093
BR - Brasile 490
SE - Svezia 469
HK - Hong Kong 463
DE - Germania 340
VN - Vietnam 248
RU - Federazione Russa 192
KR - Corea 179
UA - Ucraina 176
FI - Finlandia 149
FR - Francia 136
TR - Turchia 122
NL - Olanda 103
ID - Indonesia 73
BG - Bulgaria 62
CA - Canada 58
AR - Argentina 52
IN - India 51
LT - Lituania 36
IE - Irlanda 35
PL - Polonia 33
JP - Giappone 32
BD - Bangladesh 29
AT - Austria 28
BE - Belgio 28
MX - Messico 28
RO - Romania 24
ZA - Sudafrica 21
IQ - Iraq 17
CH - Svizzera 15
EC - Ecuador 15
MY - Malesia 15
ES - Italia 12
PK - Pakistan 12
CO - Colombia 10
IL - Israele 10
MA - Marocco 10
AU - Australia 9
CL - Cile 8
EG - Egitto 8
IR - Iran 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
PT - Portogallo 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
PY - Paraguay 6
AL - Albania 5
KZ - Kazakistan 5
LU - Lussemburgo 5
PE - Perù 5
TW - Taiwan 5
GR - Grecia 4
HU - Ungheria 4
KE - Kenya 4
NP - Nepal 4
PH - Filippine 4
SA - Arabia Saudita 4
BY - Bielorussia 3
LB - Libano 3
OM - Oman 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CM - Camerun 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 17.139
Città #
Santa Clara 993
Fairfield 869
Southend 821
Ashburn 714
Singapore 696
Hefei 543
Woodbridge 489
Chandler 485
Hong Kong 462
Houston 410
London 310
Seattle 287
Cambridge 277
Jacksonville 260
Wilmington 256
Nyköping 255
Dallas 237
Ann Arbor 209
Dearborn 208
Modena 201
Beijing 192
Seoul 165
Chicago 159
Los Angeles 136
San Diego 100
New York 94
Milan 89
Bologna 88
Helsinki 83
Ho Chi Minh City 83
Council Bluffs 82
Princeton 69
The Dalles 62
Munich 61
Sofia 61
Moscow 60
Hanoi 59
Izmir 54
Jakarta 52
Shanghai 50
Eugene 49
São Paulo 49
Parma 47
Rome 46
Redwood City 43
Buffalo 39
Salt Lake City 38
Bremen 36
Yalova 33
Phoenix 29
Amsterdam 27
Dublin 27
Stockholm 27
Reggio Emilia 26
Warsaw 26
Elk Grove Village 24
Nuremberg 24
Redondo Beach 24
Brussels 23
Des Moines 23
Frankfurt am Main 23
Kent 23
Tokyo 23
Florence 21
Brooklyn 20
Borzano 18
Bari 17
Turku 17
Formigine 16
Hemrik 16
Rimini 16
Rio de Janeiro 16
Tampa 16
Guangzhou 15
Montreal 15
Orem 15
Toronto 15
Columbus 14
Dong Ket 14
Vienna 14
Lappeenranta 13
San Jose 13
Sterling 13
Chennai 12
Haiphong 12
Kassel 12
Kilburn 12
Norwalk 12
Padova 12
Paris 12
Trento 12
Denver 11
Mexico City 11
Ottawa 11
Reggio Nell'emilia 11
Timisoara 11
Atlanta 10
Boardman 10
Frattamaggiore 10
Quartu Sant'Elena 10
Totale 12.015
Nome #
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 381
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 364
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 354
Non-HFE Hepatic Iron Overload. 347
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 326
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 322
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 309
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 308
Subacute copper-deficiency myelopathy in a patient with occult celiac disease 301
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 293
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 284
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 284
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 283
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. 279
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 279
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 278
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 277
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 277
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 274
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 274
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 271
Iron Regulation of Hepcidin Despite Attenuated Smad1,5,8 Signaling in Mice Without Transferrin Receptor 2 or Hfe. 268
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 263
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 260
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 247
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 241
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 240
Disease progression and liver cancer in the ferroportin disease 236
Lack of enterocyte iron accumulation in the ferroportin disease 231
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 231
Iron and steatohepatitis. 228
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 225
GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN 224
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 224
Fifty meanings of grey 222
A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox 219
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 217
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 214
The RGM/DRAGON family of BMP co-receptors. 210
Hereditary hemochromatosis. 206
Capitolo 8 "Epatopatie da accumulo: malattia di Wilson ed emocromatosi", in Sezione I "Epatiti acute e croniche" 205
SEX HORMONES DIFFERENTLY REGULATE HEPCIDIN EXPRESSION AND IRON HOMEOSTASIS IN VIVO. 198
Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype? 196
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease 193
Hereditary Hemochromatosis 191
null 186
Molecular and clinical correlates in iron overload associated with mutations in ferroportin 186
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 175
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 172
Hereditary Haemochromatosis: the genes and the disease. 169
Impact of natural neuromedin-B receptor variants on iron metabolism 167
Fortune favours the bold: finding the right route in the anemia's sea 163
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 161
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 156
Hyperferritinemia and diagnosis of type 1 Gaucher disease 156
Idiopathic brain calcification in a patient with hereditary hemochromatosis 155
A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages 152
Iron and the liver 149
Genetic iron overload disorders 149
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 148
Labile plasma iron and echocardiographic parameters are associated to cardiac events in beta-thalassemic patients 143
Iron Metabolism in the Disorders of Heme Biosynthesis 143
CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development 141
Fegato, pancreas e vie biliari. 138
Post COVID-19 irritable bowel syndrome 133
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo 132
Assistenza sanitaria primaria. Vol. 2: La formazione medica per il suo sviluppo 132
Haemochromatosis 128
Juvenile hemocromatosis associated with pathogenetic mutations of adult hemocromatosis genes 128
Iron in Porphyrias: Friend or Foe? 128
A Population-based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia 127
Use of digital technologies to support cancer screening in community health promotion interventions: scoping review 122
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia (Nature Reviews Endocrinology, (2023), 19, 5, (299-310), 10.1038/s41574-023-00807-6) 121
Consensus Statement on the definition and classification of metabolic hyperferritinaemia 119
Assistenza sanitaria primaria. Aspetti culturali, metodi e strumenti per il suo sviluppo 119
EASL Clinical Practice Guidelines on haemochromatosis 118
Role and challenges to digital technologies in community health promotion programs in Italy during the COVID-19 pandemic: a multiple embedded case study protocol 106
Iron overload disorders 103
Erratum: Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene (Blood Cells, Molecules, and Diseases (2003) 31 (299-304) DOI: 10.1016/S1079-9796(03)00164-5) 102
Developing an integrated care pathway to connect home-based palliative care and emergency departments: participatory action research on a quality improvement project 97
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders” 87
Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort 84
Corrigendum to “EASL Clinical Practice Guidelines on haemochromatosis” [J Hepatol 2022 (77) 479–502](S0168827822002112)(10.1016/j.jhep.2022.03.033) 78
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 76
Hypoparathyroidism in adults with iron overload diseases (IOD): evidence of a subclinical phenotype 75
SEX HORMONES DIFFERENTLY REGULATE HEPATIC HEPCIDIN EXPRESSION AND SYSTEMIC IRON HOMEOSTASIS IN VIVO 64
Haematological parameters in erythropoietic protoporphyria: A multi-national study 62
Prevalence of malnutrition and its impact on clinical outcomes in internal medicine wards: The SIMI-NUTRO study 53
Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome 51
Porphyrias: Pathophysiology and clinical management recommendations for hepatologists 4
Totale 17.312
Categoria #
all - tutte 71.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.251 0 0 0 0 0 200 193 303 77 160 137 181
2021/20221.503 90 127 179 58 82 65 111 104 196 107 216 168
2022/20231.571 153 165 110 137 197 208 44 177 186 39 90 65
2023/20241.179 59 68 128 118 152 83 96 159 35 83 101 97
2024/20254.019 165 48 100 255 757 593 222 223 459 193 501 503
2025/20263.945 560 426 816 817 883 443 0 0 0 0 0 0
Totale 17.312